This document discusses techniques for evaluating left ventricular function in patients with ischemic cardiomyopathy, including multigated angiography (MUGA), myocardial perfusion scintigraphy using thallium-201 or technetium-99m tracers, gated cardiac single photon emission computed tomography (SPECT), and positron emission tomography (PET). SPECT and PET can assess myocardial perfusion, function, volumes, and viability. Segmental analysis of wall motion and calculations of ejection fraction from gated imaging provide prognostic information. The identification of viable but ischemic tissue has implications for the potential benefits of revascularization.